bioAffinity Technologies, Inc. (BIAFW) Research

bioAffinity Technologies, Inc. functions as an emerging entity focused on developing innovative solutions for the critical need in non-intrusive, early cancer detection and therapeutic interventions. The firm constructs distinctive in-vitro diagnostic instruments and targeted cancer treatments, employing cutting-edge technology engineered to specifically identify and attack cancerous cells. This company was established on March 26, 2014, with its principal offices situated in San Antonio, Texas.

Market snapshot

Symbol
BIAFW
Price
$0.14
Day change
-14.27%
Market cap
$3.8M
P/E ratio
-0.24x
52-week range
0.1202-0.47
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months

Peer companies

  • BioXcel Therapeutics, Inc. (BTAI)
  • Cryo-Cell International, Inc. (CCEL)
  • electroCore, Inc. (ECOR)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • Inotiv, Inc. (NOTV)
  • Precipio, Inc. (PRPO)
  • Rockwell Medical, Inc. (RMTI)
  • Star Equity Holdings, Inc. (STRR)

Recent insider activity

  • Rios Roberto — trade (0 shares) on 2025-08-12
  • Oppenheimer John J. — trade (0 shares) on 2025-08-12
  • Reveles Xavier Trinidad — A-Award (21604 shares) on 2025-01-10
  • GIRGENTI STEVEN — A-Award (14814 shares) on 2025-01-10
  • Zannes Maria — A-Award (37037 shares) on 2025-01-10

Open bioAffinity Technologies, Inc. (BIAFW) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.